DRUGphase1small molecule
cinnatrarx p38a inhibitor
Mechanism
p38α MAPK inhibitor. Targets stress-kinase signaling implicated in SMA motor neuron loss. Spinout from Columbia University / NU collaboration.
Related claims (0)
No claims matched “cinnatrarx p38a inhibitor” in free-text search.
Off-Target Findings (0)
No Boltz-2 / Chai-1 off-target panel claims recorded for this drug.